A Look At Intuitive Surgical (ISRG) Valuation After Strong Q1 Beat And Raised Procedure Growth Outlook

Simply Wall St.05-24

Intuitive Surgical (ISRG) is back in focus after first quarter results topped earnings and revenue forecasts, da Vinci procedure growth guidance was lifted, and fresh upgrades to its robotic surgery ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2637210372?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/30239-main-header/1756218484982","is_english":true,"pubTime":"2026-05-24 11:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2637210372","market":"nz","top_or_hot":-1,"title":"A Look At Intuitive Surgical (ISRG) Valuation After Strong Q1 Beat And Raised Procedure Growth Outlook","media":"Simply Wall St.","content":"<div>\n<p>Intuitive Surgical (ISRG) is back in focus after first quarter results topped earnings and revenue forecasts, da Vinci procedure growth guidance was lifted, and fresh upgrades to its robotic surgery ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-isrg/intuitive-surgical/news/a-look-at-intuitive-surgical-isrg-valuation-after-strong-q1\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Intuitive Surgical (ISRG) Valuation After Strong Q1 Beat And Raised Procedure Growth Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Intuitive Surgical (ISRG) Valuation After Strong Q1 Beat And Raised Procedure Growth Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-24 11:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-isrg/intuitive-surgical/news/a-look-at-intuitive-surgical-isrg-valuation-after-strong-q1><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Intuitive Surgical (ISRG) is back in focus after first quarter results topped earnings and revenue forecasts, da Vinci procedure growth guidance was lifted, and fresh upgrades to its robotic surgery ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-isrg/intuitive-surgical/news/a-look-at-intuitive-surgical-isrg-valuation-after-strong-q1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4588","symbol_name":"碎股","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-isrg/intuitive-surgical/news/a-look-at-intuitive-surgical-isrg-valuation-after-strong-q1","article_id":"2637210372","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/30239-main-header/1756218484982"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-isrg/intuitive-surgical/news/a-look-at-intuitive-surgical-isrg-valuation-after-strong-q1","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2637210372","pubTimestamp":1779593163,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Intuitive Surgical (ISRG) is back in focus after first quarter results topped earnings and revenue forecasts, da Vinci procedure growth guidance was lifted, and fresh upgrades to its robotic surgery ecosystem were outlined.\nSee our latest analysis for Intuitive Surgical.\nThe share price has been under pressure with a year to date share price return down 22.04%, although the 3 year total shareholder return of 42.75% and 5 year total shareholder return of 56.06% show longer term holders have...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4588":"碎股","ISRG":"直觉外科公司","BK4504":"桥水持仓","BK4548":"巴美列捷福持仓","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0096364046.USD":"CT (LUX) I AMERICAN \"DU\" (USD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0079474960.USD":"联博美国增长基金A","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","BK4534":"瑞士信贷持仓","LU1951198990.SGD":"Natixis Thematics AI & Robotics Fund H-R/A SGD-H","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU0058720904.USD":"联博国际健康护理基金A","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU1951200564.SGD":"Natixis Thematics AI & Robotics Fund R/A SGD","ISUL":"2倍做多ISRG ETF-GraniteShares","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","LU1868837300.USD":"CT (LUX) I AMERICAN FUND \"9\" (USD) ACC","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1923623000.USD":"Natixis Thematics AI & Robotics Fund R/A USD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1917777945.USD":"安联专题基金Cl AT Acc","LU1868836914.USD":"CT (LUX) I AMERICAN \"3\" (USD) ACC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0238689110.USD":"贝莱德环球动力股票基金","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1868837136.USD":"CT (LUX) I AMERICAN \"8\" (USD) ACC","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU1868836591.USD":"CT (LUX) I AMERICAN \"1U\"(USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC"},"translate_title":"在第一季度强劲表现并提高手术增长前景后审视Intuitive Surgical(ISRG)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISRG":1.5,"ISUL":0.6},"content_text":"Intuitive Surgical (ISRG) is back in focus after first quarter results topped earnings and revenue forecasts, da Vinci procedure growth guidance was lifted, and fresh upgrades to its robotic surgery ecosystem were outlined. See our latest analysis for Intuitive Surgical. The share price has been under pressure with a year to date share price return down 22.04%, although the 3 year total shareholder return of 42.75% and 5 year total shareholder return of 56.06% show longer term holders have still seen gains. If Intuitive Surgical’s recent move has you looking at other healthcare automation opportunities, this is a good moment to scan the 35 robotics and automation stocks. With the stock down sharply over the past year yet carrying upbeat analyst targets and solid recent execution, the key question now is simple: Is Intuitive Surgical on sale, or is the market already pricing in years of future growth? AdvertisementMost Popular Narrative: 18% Undervalued According to the most followed Simply Wall St narrative, Intuitive Surgical’s fair value of $532.46 sits above the last close at $438.10, which frames the stock as trading below that narrative estimate while analysts also see upside from current levels.  Over the next 5 years I calculate with (actual values from 18.01.26, price/shr at 533 USD): Revenue Growth p.a.: 12% (Currently at 14,7%). We saw the peak of revenue growth with nearly 15%. Now even 12% is ambitious, but with the “subscription-like” revenues from spare parts and software licences, based on a still growing base of installed systems, it appears realistic. Profit Margin: 30% (currently at 28,6%) because spare parts in general have more margin than system sales, and the sales out of spare parts is still growing. Future PE: 50 (currently at 69). The high PEs are typical for fast growers, but over time the PE will go down. I see for the next 5 years 50, in 10 years it could come down to 40. Interest rate: 6,77% (same as current). This leads to an FV of 533 USD, which means ISRG trades with 0,5% at fair value.  Read the complete narrative. Want to see what sits behind that fair value number? The narrative leans on steady revenue expansion, firming margins and a still rich profit multiple. Curious how those moving parts combine into a single valuation call? Result: Fair Value of $532.46 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, that fair value story could be challenged if procedure growth slows meaningfully or if hospitals delay system upgrades and service contracts more than expected. Find out about the key risks to this Intuitive Surgical narrative. Another View: High Multiple Signals Caution The popular fair value narrative paints Intuitive Surgical as 18% undervalued, but the market’s own pricing tells a different story. At a P/E of 52.1x versus 24.5x for the US Medical Equipment industry, 26.7x for peers, and a fair ratio of 32.2x, the stock is priced at a clear premium. That gap can reflect quality, but it also raises the risk that even solid execution might not be enough if expectations cool. For investors weighing how much this premium matters day to day, our valuation breakdown goes deeper into why the current P/E sits so far above the fair ratio and sector norms, and what that could mean if sentiment shifts. See what the numbers say about this price — find out in our valuation breakdown. NasdaqGS:ISRG P/E Ratio as at May 2026Next Steps After weighing the bullish fair value story against that rich P/E, where do you land on the stock today? Act while the details are fresh and review the 3 key rewards Looking for more investment ideas? If Intuitive Surgical has sharpened your focus on quality, now is the time to broaden your watchlist with a few targeted stock ideas that fit your style.  Target potential bargains by scanning 49 high quality undervalued stocks that pair strong fundamentals with prices that sit below their estimated worth. Build a steadier income stream by reviewing 10 dividend fortresses that aim to combine higher yields with resilience. Prioritize resilience first by checking 67 resilient stocks with low risk scores that score well on financial strength and risk metrics.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2637210372","isCrawlerRequest":true}